Brightsurf Science News & Current Events

January 01, 2003
Study employs backyard scientists to document global warming impact
The flora and fauna are sending signals about the impact of global warming - a message that is being heard in backyards around the world.

Antegren® (natalizumab) clinical study results published in New England Journal of Medicine
Elan Corporation, plc (NYSE: ELN) (

Breakthrough brings laser light to new regions of the spectrum
Combining concepts from electromagnetic radiation research and fiber optics, researchers have created an extreme-ultraviolet, laser-like beam capable of producing tightly-focused light in a region of the electromagnetic spectrum not previously accessible to scientists.

Effects of global warming already being felt on plants and animals worldwide
Global warming is having a significant impact on hundreds of plant and animal species around the world - although the most dramatic effects may not be felt for decades, according to a new study in the journal Nature.

Researchers discover new test for genetic disease related to Parkinson's
UCSF and OHSU researchers have discovered a new method of diagnosing a genetic disorder related to Parkinson's disease through the use of MRI.

Volcanoes on Jovian moon spew salt into atmosphere
Astronomers have solved a nearly 30-year-old mystery surrounding Jupiter's moon Io, showing that volcanoes there appear to be shooting gaseous salt into the moon's thin atmosphere.

Stanford research shows medications underused in treating heart disease
Past studies have shown that various medications including beta blockers and aspirin can help manage heart disease.

Cocaine harms brain's 'pleasure center,' addict study finds
New research strongly suggests that cocaine bites the hand that feeds it, by harming or even killing the very brain cells that trigger the

Clinical study results published in NEJM show promising data on Antegren® (natalizumab)
Biogen, Inc. (NASDAQ:BGEN) and Elan Corporation, plc (NYSE:ELN) announced today that the results of a study published in the New England Journal of Medicine (NEJM) indicate ANTEGREN®(natalizumab) reduced new inflammatory brain lesions and relapses in patients with relapsing forms of multiple sclerosis (MS). is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to